Mimedx (MDXG) Net Cash Flow (QoQ) (2011 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Net Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Mimedx | 671.73 Mn | 535.89 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -277.03% |
| Mar 31, 2026 | -126.41% |
| Dec 31, 2025 | 3.55% |
| Sep 30, 2025 | 86.64% |
| Jun 30, 2025 | 517.27% |
| Mar 31, 2025 | -87.09% |
| Dec 31, 2024 | -21.00% |
| Sep 30, 2024 | -4.39% |
| Jun 30, 2024 | 163.21% |
| Mar 31, 2024 | -21,559.60% |
| Dec 31, 2023 | -101.18% |
| Sep 30, 2023 | -21.20% |
| Jun 30, 2023 | 444.07% |
| Mar 31, 2023 | 34.93% |
| Dec 31, 2022 | -1,116.36% |
| Sep 30, 2022 | 122.53% |
| Jun 30, 2022 | 72.17% |
| Mar 31, 2022 | 0.08% |
| Dec 31, 2021 | -303.86% |
| Sep 30, 2021 | 2,045.59% |